📣 VC round data is live. Check it out!
- Public Comps
- Great Tree Pharmacy
Great Tree Pharmacy Valuation Multiples
Discover Great Tree Pharmacy's revenue and EBITDA valuation multiples and investment history, alongside public comparables like Dimed SA, YSB, JZJ Chain Drugstore, DocMorris and more.
Great Tree Pharmacy Overview
About Great Tree Pharmacy
Great Tree Pharmacy Co Ltd is engaged in the management and trade of various drugs, health products, goods for mothers and babies, and cosmetics products. The firm also provides coordinated medicine procurement services to various clinics, outpatient centers, and medical communities. Besides, the company is also an agency for domestic and foreign healthcare products sold in clinics, outpatient centers, and medical communities.
Founded
2001
HQ

Employees
2.3K
Website
Sectors
Financials (LTM)
EV
$491M
Valuation Multiples
Start free trialGreat Tree Pharmacy Financials
Great Tree Pharmacy reported last 12-month revenue of $624M and EBITDA of $50M.
In the same LTM period, Great Tree Pharmacy generated $180M in gross profit, $50M in EBITDA, and $20M in net income.
Revenue (LTM)
Great Tree Pharmacy P&L
In the most recent fiscal year, Great Tree Pharmacy reported revenue of $605M and EBITDA of $55M.
Great Tree Pharmacy is profitable as of last fiscal year, with gross margin of 29%, EBITDA margin of 9%, and net margin of 3%.
Financial data powered by Morningstar, Inc.
Great Tree Pharmacy Stock Performance
Great Tree Pharmacy has current market cap of $347M, and enterprise value of $491M.
Market Cap Evolution
Great Tree Pharmacy's stock price is $2.31.
Great Tree Pharmacy share price increased by 1.8% in the last 30 days, and decreased by 44.5% in the last year.
Great Tree Pharmacy has an EPS (earnings per share) of $0.13.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $491M | $347M | 1.7% | 1.8% | -10.0% | -44.5% | $0.13 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialGreat Tree Pharmacy Valuation Multiples
Great Tree Pharmacy trades at 0.8x EV/Revenue multiple, and 9.7x EV/EBITDA.
EV / Revenue (LTM)
Great Tree Pharmacy Financial Valuation Multiples
As of June 3, 2026, Great Tree Pharmacy has market cap of $347M and EV of $491M.
Great Tree Pharmacy has a P/E ratio of 17.1x.
Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified Great Tree Pharmacy Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.


Great Tree Pharmacy Margins & Growth Rates
Great Tree Pharmacy grew revenue by 7% but EBITDA decreased by 6% in the last fiscal year.
In the most recent fiscal year, Great Tree Pharmacy reported gross margin of 29%, EBITDA margin of 9%, and net margin of 3%.
Great Tree Pharmacy Margins
Great Tree Pharmacy Growth Rates
Data powered by FactSet, Inc. and Morningstar, Inc.
Great Tree Pharmacy Operational KPIs
Great Tree Pharmacy's revenue per employee in the last FY averaged $0.3M, while opex per employee averaged $0.1M for the same period.
Great Tree Pharmacy's Rule of 40 is 16% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
Great Tree Pharmacy's Rule of X is 28% (created by Bessemer, Rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
Data powered by FactSet, Inc. and Morningstar, Inc.
Great Tree Pharmacy Competitors
Great Tree Pharmacy competitors include Dimed SA, YSB, JZJ Chain Drugstore, DocMorris, Cawachi, Fangzhou, Green Cross Health, Profarma, Pague Menos and Cachet Pharmaceuticals.
Most Great Tree Pharmacy public comparables operate across Pharmacies.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| Last FY | LTM | 2027E | Last FY | LTM | 2027E | |
| 0.5x | 0.5x | 5.4x | 8.2x | |||
| 0.0x | - | 2.2x | - | |||
| 0.7x | - | 5.5x | - | |||
| 0.4x | 0.4x | (11.4x) | (11.5x) | |||
| 0.2x | 0.2x | 4.6x | - | |||
| 0.3x | 0.2x | 27.3x | 21.5x | |||
| 0.7x | - | 7.8x | - | |||
| 0.2x | - | 4.1x | - | |||
This data is available for Pro users. Sign up to see all Great Tree Pharmacy competitors and their valuation data. Start Free Trial | ||||||
Investments by Great Tree Pharmacy
Great Tree Pharmacy has invested in 1 company to date.
Latest investment by Great Tree Pharmacy was on July 5th 2023. Great Tree Pharmacy invested in Annji Pharmaceutical in their $21M Undisclosed stage round (EV/Revenue multiple available to Pro users).
Latest Investments by Great Tree Pharmacy
| Description | Annji Pharmaceutical Co Ltd is an R&D based, clinical-stage new drug company dedicated to the development of first-in-class small molecules focusing on indications with highly unmet needs in the therapeutic areas of neurology, dermatology, and inflammatory disorders, including rare diseases such as idiopathic pulmonary fibrosis and Kennedy’s disease, or SBMA (Spinal and bulbar muscular atrophy). Its pipeline products include AJ201, AJ302 and AJ303. |
| HQ Country | |
| HQ City | Taipei |
| Deal Date | 5 Jul 2023 |
| Round | Undisclosed stage |
| Raised | $21M |
| Investors | Black Marble Capital Management; Blackwood Capital; Cathay Financial Holdings; Chang Hwa Bank; Fubon Financial; GAINS Investment Corp.; Great Tree Pharmacy; Hotung Venture Capital; Solaris Ventures; Taiwan Business Bank; Taiwan Cooperative Bank; TopTaiwan |
| Valuation | undisclosed |
| EV/Revenue | |
| EV/EBITDA | |
This data is available for Pro users. Sign up to see all Great Tree Pharmacy investments and their VC round multiples. Start Free Trial | |
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout Great Tree Pharmacy
| When was Great Tree Pharmacy founded? | Great Tree Pharmacy was founded in 2001. |
| Where is Great Tree Pharmacy headquartered? | Great Tree Pharmacy is headquartered in Taiwan. |
| How many employees does Great Tree Pharmacy have? | As of today, Great Tree Pharmacy has over 2K employees. |
| Is Great Tree Pharmacy publicly listed? | Yes, Great Tree Pharmacy is a public company listed on Taipei Exchange. |
| What is the stock symbol of Great Tree Pharmacy? | Great Tree Pharmacy trades under 6469 ticker. |
| When did Great Tree Pharmacy go public? | Great Tree Pharmacy went public in 2014. |
| Who are competitors of Great Tree Pharmacy? | Great Tree Pharmacy main competitors include Dimed SA, YSB, JZJ Chain Drugstore, DocMorris, Cawachi, Fangzhou, Green Cross Health, Profarma, Pague Menos, Cachet Pharmaceuticals. |
| What is the current market cap of Great Tree Pharmacy? | Great Tree Pharmacy's current market cap is $347M. |
| What is the current revenue of Great Tree Pharmacy? | Great Tree Pharmacy's last 12 months revenue is $624M. |
| What is the current revenue growth of Great Tree Pharmacy? | Great Tree Pharmacy revenue growth (NTM/LTM) is 8%. |
| What is the current EV/Revenue multiple of Great Tree Pharmacy? | Current revenue multiple of Great Tree Pharmacy is 0.8x. |
| What is the current EBITDA of Great Tree Pharmacy? | Great Tree Pharmacy's last 12 months EBITDA is $50M. |
| What is Great Tree Pharmacy's EBITDA margin? | Great Tree Pharmacy's last 12 months EBITDA margin is 8%. |
| What is the current EV/EBITDA multiple of Great Tree Pharmacy? | Current EBITDA multiple of Great Tree Pharmacy is 9.7x. |
| What is the current FCF of Great Tree Pharmacy? | Great Tree Pharmacy's last 12 months FCF is $25M. |
| What is Great Tree Pharmacy's FCF margin? | Great Tree Pharmacy's last 12 months FCF margin is 4%. |
| What is the current EV/FCF multiple of Great Tree Pharmacy? | Current FCF multiple of Great Tree Pharmacy is 19.7x. |
| How many companies Great Tree Pharmacy has acquired to date? | Great Tree Pharmacy hasn't acquired any companies yet (or none have been disclosed publicly). |
| In how many companies Great Tree Pharmacy has invested to date? | As of June 2026, Great Tree Pharmacy has invested in 1 company. |
| What was the last Great Tree Pharmacy investment? | On 5th July 2023 Great Tree Pharmacy invested in Annji Pharmaceutical, participating in a $21M Undisclosed stage round, alongside Black Marble Capital Management, Blackwood Capital, Cathay Financial Holdings, Chang Hwa Bank, Fubon Financial, GAINS Investment Corp., Hotung Venture Capital, Solaris Ventures, Taiwan Business Bank, Taiwan Cooperative Bank, and 1 other investor. |
| In what companies Great Tree Pharmacy invested in? | Great Tree Pharmacy invested in Annji Pharmaceutical. |
See public comps similar to Great Tree Pharmacy
Lists including Great Tree Pharmacy
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.
